Vasostatin as marrow protectant
Patent Number: 6596690
Date of First Priority Issue: Tuesday October 6th, 1998
Date Issued: Tuesday July 22nd, 2003
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: Tosato, Giovanna (Bethesda, MD); Pike, Sandra E. (North Bethesda, MD); Yao, Lei (Rockville, MD)
From Class: Expansion
Comments: No comments
This patent covers the new use of vasostatin in inhibiting the killing of stem cells from agents that are cytotoxic the mitotic cells such as radiation and chemotherapy.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.